The Opioid Crisis in Canada: Rising OD Deaths Demand Action
Canada’s rising OD deaths, particularly affecting young adults, demand urgent policy improvements and intervention strategies against the escalating opioid crisis.
April 2024
“Quebec Court Approval of Class Action Against Opioid Producers: A Critical Step in the Fight Against the Crisis”
Quebec court greenlights class action against opioid producers for misleading consumers, deepening the crisis.็
The Opioid Crisis in Canada: Urgent Call for Policy Change
The opioid crisis in Canada demands urgent attention and better policies to combat the rising deaths among young Canadians.
Unmasking Canada’s Opioid Crisis: Alarming Stats & Urgent Action
The opioid crisis claims over 25% of young Canadian lives, a pressing issue requiring urgent action and support.
The Quest for Non-Addictive Painkillers in Canada’s Opioid Crisis
Amidst Canada’s opioid crisis, Vertex Pharmaceuticals strives to develop non-addictive painkillers as a proactive solution. Collaboration among diverse stakeholders is key.
The Canadian Opioid Crisis: Urgent Call for Action
The Canadian opioid crisis demands immediate action to address escalating death tolls and societal repercussions.
Understanding Manitoba’s Escalating Opioid Crisis
“Manitoba struggles with rising opioid deaths, averaging more than one death per day in late 2020. Street drugs laced with synthetics increase overdose risk.”
“The Canadian Opioid Crisis: Impact, Challenges, and Solutions”
The Canadian opioid crisis continues to devastate communities, with over 20,000 deaths since 2016. Indigenous communities are hardest hit by this ongoing tragedy.
“Canadian Opioid Crisis: Urgent Call for Change”
The Canadian opioid crisis demands immediate and comprehensive policy changes to combat rising overdose deaths, especially among young adults. #OpioidCrisis
Unraveling the Newfoundland-Labrador Opioid Crisis: Strategies and Socio-Economic Interconnections
Averting Crisis: Newfoundland-Labrador combats opioid crisis while addressing crab pricing challenges, showcasing the intersection of health and economy.